Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

As expected, based on established risk factors for MS, a higher proportion of case participants had a history of smoking or a history of infectious mononucleosis compared to control participants, and the mean circulating concentration of 25(OH)D was lower in case participants than control participants.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We used data from the Ausimmune Study, a large, multi-centre case: control study conducted in four latitudinally diverse regions of Australia.

Source: Abstract.

Participants aged 18 to 59 years were recruited from 2003 to 2006 as reported elsewhere [].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Higher dietary choline and betaine intakes are associated with lower likelihood of central nervous system demyelination in Australian women

Case-control study · European Journal of Nutrition · 2026

Original publication title

Higher dietary choline and betaine intakes are associated with lower likelihood of central nervous system demyelination in Australian women

Paul Bailey; Hajar Mazahery; Lucinda J. Black; Alison Daly; Yasmine Probst; Ingrid van der Mei; Eleanor Dunlop

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Given the potential beneficial role of choline and betaine in MS, investigation of associations and any diet: or sex-specific influences in other populations is warranted.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Choline and betaine may be neuroprotective; however, the role of choline and betaine obtained from food in multiple sclerosis (MS) onset in humans is unclear. We aimed to test associations between intake of choline and betaine from food and likelihood of a first clinical diagnosis of central nervous system demyelination (FCD).

Source: Purpose

Abstract: What methods does the paper describe?

We used data from the Ausimmune Study, a large, multi-centre case: control study conducted in four latitudinally diverse regions of Australia. Choline and betaine intakes were derived from food composition data sourced globally and dietary intake data collected using a self-administered, semiquantitative food frequency questionnaire. We used the alternate Mediterranean diet score (aMED) as a measure of diet quality. We applied logistic regression with full propensity score matching (264 cases, 474 controls) and stratified by sex (females: 205 cases/368 controls; males 59 cases/106 controls) to test associations between dietary choline and betaine intakes (per 50 mg/day) and likelihood of an FCD.

Models were adjusted for age, region, education, smoking history, history of infectious mononucleosis, deseasonalised serum 25-hydroxyvitamin D concentration, total energy intake, dietary misreporting and aMED, and bootstrapped (500 replicates).

Source: Methods

Abstract: Results

Independent of an overall healthy diet, higher choline intake (OR = 0.91; 95%CI 0.84 to 1.00; p = 0.05) and higher combined choline + betaine intake (OR = 0.92; 95%CI 0.86 to 0.99; p = 0.03) were significantly associated with lower likelihood of FCD in females only. We found no statistically significant associations in males (small sample).

Source: Results

Abstract: Conclusion

Given the potential beneficial role of choline and betaine in MS, investigation of associations and any diet: or sex-specific influences in other populations is warranted.

Source: Conclusion
Authors’ abstract

Purpose

Choline and betaine may be neuroprotective; however, the role of choline and betaine obtained from food in multiple sclerosis (MS) onset in humans is unclear. We aimed to test associations between intake of choline and betaine from food and likelihood of a first clinical diagnosis of central nervous system demyelination (FCD).

Methods

We used data from the Ausimmune Study, a large, multi-centre case: control study conducted in four latitudinally diverse regions of Australia. Choline and betaine intakes were derived from food composition data sourced globally and dietary intake data collected using a self-administered, semiquantitative food frequency questionnaire. We used the alternate Mediterranean diet score (aMED) as a measure of diet quality. We applied logistic regression with full propensity score matching (264 cases, 474 controls) and stratified by sex (females: 205 cases/368 controls; males 59 cases/106 controls) to test associations between dietary choline and betaine intakes (per 50 mg/day) and likelihood of an FCD.

Models were adjusted for age, region, education, smoking history, history of infectious mononucleosis, deseasonalised serum 25-hydroxyvitamin D concentration, total energy intake, dietary misreporting and aMED, and bootstrapped (500 replicates).

Results

Independent of an overall healthy diet, higher choline intake (OR = 0.91; 95%CI 0.84 to 1.00; p = 0.05) and higher combined choline + betaine intake (OR = 0.92; 95%CI 0.86 to 0.99; p = 0.03) were significantly associated with lower likelihood of FCD in females only. We found no statistically significant associations in males (small sample).

Conclusion

Given the potential beneficial role of choline and betaine in MS, investigation of associations and any diet: or sex-specific influences in other populations is warranted.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00394-026-03915-x.

Publication and source details

Original title: Higher dietary choline and betaine intakes are associated with lower likelihood of central nervous system demyelination in Australian women

Paul Bailey; Hajar Mazahery; Lucinda J. Black; Alison Daly; Yasmine Probst; Ingrid van der Mei; Eleanor Dunlop

European Journal of Nutrition · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Deakin University

Open Access funding enabled and organized by CAUL and its Member Institutions

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:02:45.200387+00:00

DOI: 10.1007/s00394-026-03915-x · PMC12906510